CTOs on the Move

Hooper Holmes

www.hooperholmes.ca

 
Hooper Holmes is a data-driven leader in collecting personal health data and transforming it into useful information, which in turn, enables our customers to take actions that manage or reduce their risks and expenses. As the foremost provider of risk assessment services for the insurance industry, we are the only company that can provide insurers with ALL the services they need to reach their ultimate goal: complete policy medical exam, data collection, laboratory testing, inspection reports and underwriting services in the industry. Each year we arrange more medical exams than any other company and process millions of specimens in our ...
  • Number of Employees: 25-100
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Transcend Services

Transcend Services, Inc. (Transcend) provides medical transcription services to the healthcare industry. The Company provides two primary medical transcription options for customers: the provision of transcription services and technology using the

NHOH

NHOH is a Hooksett, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

iSource Solutions,

iSource Solutions, is a Diamond Bar, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WebOps

WebOps is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.